期刊文献+

2000-2014年中国肿瘤登记地区肝癌发病年龄变化趋势分析 被引量:39

Trend analysis of age of diagnosis for liver cancer in cancer registry areas of China,2000-2014
原文传递
导出
摘要 目的了解2000—2014年中国肝癌平均发病年龄变化趋势.方法基于2000年1月1日至2014年12月31日间22个具有连续发病资料的肿瘤登记处新发肝癌数据,按肝癌病例出生年份计算1925—1994年的出生队列发病率,并按肝癌病例发病年龄计算年龄别发病率等统计指标.采用国际Segi's标准人口进行年龄结构标准化,利用线性回归模型分析平均发病年龄变化趋势.结果2014年肿瘤登记地区80岁以上人群发病率为108.21/10万,30~39岁人群发病率为5.09/10万.2000—2014年肝癌平均发病年龄上升,男性肝癌平均发病年龄由2000年的58.80岁增加至2014年的62.35岁(t=18.70,P〈0.001),女性则由64.02岁增加至68.99岁(t=20.50,P〈0.001).同时,2014年肝癌70岁以上组的发病构成比为25.05%,高于2000年的22.49%.结论2000—2014年我国肝癌平均发病年龄上升. Objective To investigate trends of mean age of diagnosis for liver cancer during 2000 to 2014, which may provide basic information for making feasible cancer prevention strategies. Methods Based on the continuous cancer incidence data from 22 cancer registries of China between 1 January 2000 and 31 December 2014, the incidence by birth-cohort (year of birth between 1925 and 1994) and age specific incidence rates were calculated. The incidence of different age groups were also calculated. World Segi 's population was used for age standardization. The liner regression model was applied to analyze the changing trend of mean age of diagnosis. Results In 2014, the incidence rate for population with 80 years older and above was 108.21 per 100000, whereas the rate for population at 30-39 years old was 5.09 per 100000. But the mean age of diagnosis for liver cancer showed an increasing trend from 2000 to 2014. For male, it had increased from 58.80 to 62.35(t=18.70,P〈0.001). For female, it had increased from 64.02 to 68.99(t=20.50, P〈0.001). After age standardization, the mean age of diagnosis still showed increasing trend. Meanwhile, the proportion of liver cancer in people above 70 years old was 25.05%in 2014, which was higher than that in 2000 (22.49%). Conclusion The mean age of liver cancer incidence was increasing during 2000-2014.
作者 曾红梅 曹毛毛 郑荣寿 张思维 蔡建强 曲春枫 毕新宇 邹小农 陈万青 赫捷 Zeng Hongmei;Cao Maomao;Zheng Rongshou;Zhangs Siwei;Cai Jianqiang;Qu Chunfeng;Bi Xinyu;Zou Xiaonong;Chen Wanqing;He Jie(Office for Cancer Registry, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beifing 100021, China;Program Office for Cancer Screening in Urban China, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China)
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2018年第6期573-578,共6页 Chinese Journal of Preventive Medicine
基金 国家重点研发计划(2017YFC0908103) 中国医学科学院医学与健康科技创新工程(2016-12M-2-004) 国家自然科学基金(81602931)
关键词 肝肿瘤 中国 横断面研究 平均发病年龄 人口老龄化 Liver neoplasms China Cross-sectional studies Mean age of diagnosis Aging population
  • 相关文献

参考文献7

二级参考文献46

  • 1Chun Gao, Hong-Chuan Zhao, Jing-Tao Li, Shu-Kun Yao.Diabetes mellitus and hepatocellular carcinoma:Comparison of Chinese patients with and without HBV-related cirrhosis[J].World Journal of Gastroenterology,2010,16(35):4467-4475. 被引量:14
  • 2孙玉环.X-12-ARIMA方法的SAS程序实现及应用[J].统计与决策,2006,22(4):138-141. 被引量:6
  • 3Iloeje UH,Yang HI,Su J,陆伟(摘译),张占卿(审校).根据循环乙型肝炎病毒载量预测肝硬化的危险性[J].世界感染杂志,2006,6(4):396-396. 被引量:202
  • 4Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015, 65 (2) : 87-108. DOI: 10.3322/ caac. 21262.
  • 5E1-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma [J]. Gastroenterology, 2012, 142 (6) : 1264-1273. DOI : 10.1053/j.gastro.2011.12.061.
  • 6Yang GH, Wang Y, Zeng YX, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010 [J]. Lancet, 2013, 381 (9882) : 1987-2015. DOI: 10.1016/S0140-6736( 13 )61097-1.
  • 7Murray CJL, Lopez AD. Measuring the global burden of disease [J]. N Eng J Med, 2013, 369 (5) : 448-457. DOI: 10.1056/ NEJMral201534.
  • 8Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics [J]. Lancet, 2012, 380 (9859) : 2063-2066. DOI: 10.1016/S0140-6736( 12)61899-6.
  • 9GBD 2013. Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-canse and cause- specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 [J]. Lancet, 2015, 385 (9963) : 117-171. DOI: 10.1016/ S0140-6736( 14)61682-2.
  • 10Zhou MG, Wang HD, Zhu J, et al. Canse-specific mortality for 240 causes in China during 1990-2013:a systematic sub national analysis for the Global Burden of Disease Study 2013 [J]. Lancet, 2016,387(10015) : 251-272. DOI: 10.1016/S0140-6736 (15)00551-6.

共引文献161

同被引文献346

引证文献39

二级引证文献1240

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部